Rutgers Pharmaceutical Industry Program

Please join us for our two webinars this fall on September 20th and November 20th.
Please RSVP here: http://tinyurl.com/RutgersFellowship
Fellowship Information and Networking Day (FIND) will be held on Friday, November 17th, 2017 at the Rutgers Ernest Mario School of Pharmacy. Click here to learn more.


Current News

September 21, 2017
Check out our Calendar for Updates!

Please be sure to check out our Events Calendar for updates with Rutgers Outreach Visits - over the next few months, our fellows will be traveling and presenting at various Regional Meetings, Conferences, and University Visits.

Look for Rutgers fellows coming to an event near you to learn more about our distinguished program!

September 07, 2017
Fall 2017 RPIF Outreach Visits and Webinars

Welcome back to a new Fall semester! Check out the Events Calendar as we prepare for upcoming webinars and site visits to the various colleges of pharmacy throughout the nation. We may be stopping by a campus near you very soon!

August 30, 2017
History in the Making: FDA approves first gene therapy in the United States

The FDA approved Kymriah (tisagenlecleucel) today, a cell-based gene therapy, that has produced unprecedented results in patients with Acute Lymphocytic Leukemia (ALL). The Novartis therapy is approved for pediatric and young adult patients up to 25 years old with B-cell precursor ALL that is refractory or in second or later relapse.

Kymriah is a genetically-modified autologous T-cell immunotherapy. Each dose is a customized treatment created using an individual patient’s own T-cells. The patient’s T-cells are collected and sent to a manufacturing center where they are genetically modified to include a new gene that contains a specific protein (a chimeric antigen receptor or CAR) that directs the T-cells to target and kill leukemia cells that have a specific antigen (CD19) on the surface. Once the cells are modified, they are infused back into the patient to kill the cancer cells.

The price tag is $475,000 for a course of treatment - and analysts say it's a bargain.

The Rutgers Pharmaceutical Industry Fellowship Program is an industry-based training program which partners with the leading pharmaceutical and bio-pharmaceutical companies. The program is designed for individuals with a Doctorate of Pharmacy to further their experience in the pharmaceutical industry through work experience and clinical research.

Our Mission Statement

The Rutgers Ernest Mario School of Pharmacy Pharmaceutical Industry Fellowship Program is a structured program designed to provide hands-on training in functions ranging from coordinating clinical trials to liaising with regulatory agencies and research organizations, while preparing pharmacists for challenging positions within the pharmaceutical industry.

Events Calendar

Program Video

View our current program video by clicking the image below.

Social Media Accounts

Follow our Rutgers Fellowship Instagram account to experience what life is like as a fellow!